Documentos de Loeb M. | REDI

Regresar

Mostrando 4 resultados de: 4

Subtipo de publicación

Publisher

The Lancet Respiratory Medicine(1)

Área temáticas

Enfermedades(4)

Medicina y salud(4)

Farmacología y terapéutica(2)

Funcionamiento de bibliotecas y archivos(1)

Problemas sociales y servicios a grupos(1)

Área de conocimiento

Ensayo clínico(2)

Medicina interna(2)

Epidemiología(1)

Farmacología(1)

Año de Publicación

Origen

Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial

Abstract: Background: The large number of patients worldwide infected with the SARS-CoV-2 virus has overwhelme

Palabras claves:

Ali Z., Anand S.S., Avezum A.J., Bangdiwala S.I., Belley-Cote E.P., Berwanger O., Bosch J.J., Choudhri S., Dans A.L., Eikelboom J.W., Farkouh M.E., Felix Camilo, Harper W.L., Hassany M., Heenan L., Jolly S.S., Kontsevaya A., Loeb M., Lopes R.D., Pais P., Palileo-Villanueva L.M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Sharma S.K., Tarhuni W.M., Wasserman S., Whitlock R.P., Xavier D., Xu L., Yusuf S., Yusufali A.M.

Drug treatments for covid-19: Living systematic review and network meta-Analysis

Abstract: AbstractObjective To compare the effects of treatments for coronavirus disease 2019 (covid-19). Desi

Palabras claves:

Agarwal A., Agoritsas T., Alexander P., Andrés Alejandro Viteri-García, Bartoszko J.J., Brignardello-Petersen R., Chu D.K., Couban R., Darzi A.J., Devji T., Fang B., Fang C., Flottorp S.A., Foroutan F., Ge L., Guyatt G.H., Han M.A., Heels-Ansdell D., Honarmand K., Hou L., Hou X., Ibrahim Q., Izcovich A., Kum E., Lamontagne F., Liu Q., Loeb M., Marcucci M., McLeod S.L., Motaghi S., Murthy S., Mustafa R.A., Neary J.D., Pardo-Hernandez H., Qasim A., Rada G., Riaz I.B., Rochwerg B., Sadeghirad B., Sekercioglu N., Sheng L., Siemieniuk R.A.C., Switzer C., Tendal B., Thabane L., Tomlinson G., Turner T., Vandvik P.O., Vernooij R.W.M., Wang Y., Yao L., Ye Z., Zeraatkar D.

Prophylaxis against covid-19: Living systematic review and network meta-analysis

Abstract: Objective To determine and compare the effects of drug prophylaxis on SARS-CoV-2 infection and covid

Palabras claves:

Agarwal A., Agoritsas T., Andrés Alejandro Viteri-García, Bartoszko J.J., Brignardello-Petersen R., Chu D.K., Couban R., Darzi A.J., Devji T., Ge L., Ghadimi M., Guyatt G.H., Han M.A., Honarmand K., Izcovich A., Khamis A., Kum E., Lamontagne F., Loeb M., Marcucci M., McLeod S.L., Motaghi S., Murthy S., Mustafa R.A., Neary J.D., Pardo-Hernandez H., Qasim A., Rada G., Rochwerg B., Sadeghirad B., Siemieniuk R.A.C., Switzer C., Tendal B., Thabane L., Vandvik P.O., Vernooij R.W.M., Wang Y., Yao L., Ye Z., Zeraatkar D.

The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges

Abstract: Background: Effective treatments for COVID-19 are urgently needed, but conducting randomized trials

Palabras claves:

Anand S.S., Avezum A.J., Bangdiwala S.I., Belley-Cote E.P., Beresh H., Berwanger O., Bosch J.J., Chan N., Choudhri S., Dans A.L., DIaz R., Eikelboom J.W., Farkouh M.E., Felix Camilo, Harper W.L., Hassany M., Jolly S.S., Kazmi K., Kontsevaya A., Lewis G., Loeb M., Lopes R.D., Nkeshimana M., Orlandini A., Pais P., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Sharma S.K., Tarhuni W.M., Wasserman S., Whitlock R.P., Xavier D., Xu L., Yusuf S., Yusufali A.M.